» Articles » PMID: 11438470

Plasmacytoid Dendritic Cells (natural Interferon- Alpha/beta-producing Cells) Accumulate in Cutaneous Lupus Erythematosus Lesions

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2001 Jul 5
PMID 11438470
Citations 236
Authors
Affiliations
Soon will be listed here.
Abstract

Plasmacytoid dendritic cell (P-DC) precursors in peripheral blood produce large amounts of interferon (IFN)-alpha/beta when triggered by viruses. However, when incubated with interleukin-3 and CD40 ligand, the same precursors differentiate into mature DCs that stimulate naïve CD4(+) T cells to produce Th2 cytokines. We recently reported that P-DCs accumulate in nasal mucosa of experimentally induced allergic rhinitis, supporting a role for this DC subset in Th2-dominated inflammation. Here we examined whether P-DCs accumulate in cutaneous lesions of lupus erythematosus (LE), a disorder associated with increased IFN-alpha/beta production. Our results showed that P-DCs were present in 14 out of 15 tissue specimens of cutaneous LE lesions, but not in normal skin. Importantly, the density of P-DCs in affected skin correlated well (r(s) = 0.79,P < 0.0005) with the high number of cells expressing the IFN-alpha/beta-inducible protein MxA, suggesting that P-DCs produce IFN-alpha/beta locally. Accumulation of P-DCs coincided also with the expression of L-selectin ligand peripheral lymph node addressin on dermal vascular endothelium, adding further support to the notion that these adhesion molecules are important in P-DC extravasation to peripheral tissue sites. Together, our findings suggested that P-DCs are an important source of IFN-alpha/beta in cutaneous LE lesions and may therefore be of pathogenic importance.

Citing Articles

Enhancement of CD8T cell cytotoxicity activity by IFN-α implies alternative pathologic role in systemic lupus erythematosus.

Zhang C, Mao Y, Tan Y, Zhang M, Shao K, Wang S J Transl Autoimmun. 2025; 10:100276.

PMID: 39995790 PMC: 11849641. DOI: 10.1016/j.jtauto.2025.100276.


Therapeutically targeting proinflammatory type I interferons in systemic lupus erythematosus: efficacy and insufficiency with a specific focus on lupus nephritis.

Lai B, Luo S, Lai J Front Immunol. 2024; 15:1489205.

PMID: 39478861 PMC: 11521836. DOI: 10.3389/fimmu.2024.1489205.


Systemic lupus erythematosus: pathogenesis and targeted therapy.

Su X, Yu H, Lei Q, Chen X, Tong Y, Zhang Z Mol Biomed. 2024; 5(1):54.

PMID: 39472388 PMC: 11522254. DOI: 10.1186/s43556-024-00217-8.


Biomarkers for systemic lupus erythematosus: A scoping review.

Zhang S, Xu R, Kang L Immun Inflamm Dis. 2024; 12(10):e70022.

PMID: 39364719 PMC: 11450456. DOI: 10.1002/iid3.70022.


Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection.

Arkin L, Costa-da-Silva A, Frere J, Ng A, Sharma R, Moon J iScience. 2024; 27(8):110525.

PMID: 39156641 PMC: 11326933. DOI: 10.1016/j.isci.2024.110525.


References
1.
Vallin H, Perers A, Alm G, Ronnblom L . Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J Immunol. 1999; 163(11):6306-13. View

2.
Herrmann M, Hagenhofer M, Kalden J . Retroviruses and systemic lupus erythematosus. Immunol Rev. 1996; 152:145-56. DOI: 10.1111/j.1600-065x.1996.tb00914.x. View

3.
Kadowaki N, Antonenko S, Lau J, Liu Y . Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med. 2000; 192(2):219-26. PMC: 2193254. DOI: 10.1084/jem.192.2.219. View

4.
Bave U, Alm G, Ronnblom L . The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J Immunol. 2000; 165(6):3519-26. DOI: 10.4049/jimmunol.165.6.3519. View

5.
Jahnsen F, Lund-Johansen F, Dunne J, Farkas L, Haye R, Brandtzaeg P . Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol. 2000; 165(7):4062-8. DOI: 10.4049/jimmunol.165.7.4062. View